Aktis Oncology, Inc. (AKTS) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aktis Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.451 Good day, ladies and gentlemen, and welcome to the Acoustis Technologies Fiscal 2023 00:00:04.451 -- 00:00:09.634 Second Quarter Conference Call. As a reminder, this conference call is being recorded. 00:00:09.634 -- 00:00:14.496 At the conclusion of the company presentation, Acoustis Management will take questions. 00:00:14.496 -- 00:00:19.779 To ask a question, please press star 1 on your keypad to be placed into queue. 00:00:19.779 -- 00:00:23.601 A replay of the call will be available on the Investor Relations section of the Acoustis 00:00:23.601 -- 00:00:25.601 website. 00:00:26.102 -- 00:00:29.264 Thank you, Operator, and good morning to everyone on the call. 00:00:29.264 -- 00:00:32.666 Welcome to ACUSTA's second quarter fiscal 2023 00:00:32.666 -- 00:00:37.749 conference call. We are joined today by our founder and CEO, Jeff Shealy, CFO 00:00:37.749 -- 00:00:42.593 Ken Bowler, and EVP of business development, Dave Eichle. 00:00:42.593 -- 00:00:47.376 Before we begin, please note that today's presentation includes forward-looking statements 00:00:47.376 -- 00:00:51.999 about our business outlook. All statements other than statements of historical facts 00:00:51.999 -- 00:00:57.102 included in this conference call, such as expectations regarding our strategies, 00:00:57.102 -- 00:01:02.352 operations, costs, plans and objectives, including the timing and prospects 00:01:02.352 -- 00:01:07.394 of product development and customer orders, our expectations regarding achieving 00:01:07.394 -- 00:01:12.717 design wins from current and future customers, the possibility of entering into collaborative 00:01:12.717 -- 00:01:18.219 or partnering relationships, potential impacts of the COVID-19 pandemic, litigation 00:01:18.219 -- 00:01:...